GBA's "2021 Stock Phantasma"

Ok so all we need is that 1st good idea to kick off the new year.

ARCT- REBOUND FROM SELL OFF VACCINE NAME

SNAP- VAN'S SNAPPY PICK

The two early candidates. Here's another) ) )

Sept 1st Salesforce peaked CRM-- $281. And of course they outright STOLE Slack-!
$222 now.

Salesforce.com, inc. (CRM) It's official every idea worked!
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
231.77+3.01 (+1.32%)
As of 12:26PM EDT. Market open.
 
I think CureVac comes back in play now. They have been quite far behind but now with problems showing up at J&J maybe they get a second look by investors. It helps that their mechanism is similar to Moderna's & Pfizer. Meaning No blood clots most likely.

CureVac
CureVac CVAC has entered partnerships with Bayer and GlaxoSmithKline earlier in 2021 after showing promise in its animal trials.

CureVac will use messenger RNA techniques, similar to those used by Pfizer and Moderna, to develop a multi-variant vaccine candidate that the pair hope will be available in 2022.////

CVAC-$94.35
 
In the prior thread "Ideas For Now" we made a bundle on CVAC!! And now we are back on the horse. I am expecting a JUNE BLASTOFF FDA OK!!!<----- Earnings report coming up is a chance to explain where we are at timeline wise..

- Companies tech seems to me to be especially relevant for Variants and tweaking. Perhaps theirs will come out British variant ready! <--- Also crazy partner deal with Elon Musk and Tesla to create a 3D Vaccine printing machine... That would print up the type you want on site... lets go a little heavier on the Brazil variant please and a dash of South Africa...just a dash... and a whole lot of NYC!-
 
Back
Top